AI-generated summary
The authors randomly assigned 14 patients with high brachial plexus injury, who had undergone the Oberlin nerve transfer to restore elbow flexion, to either photobiomodulation or a control group. At 3 months, more patients receiving photobiomodulation showed signs of reinnervation and their mean muscle power was higher, with no adverse effects reported. The study's small sample size limits how strongly these results can be generalized.
- Participants
- 14
- Who or what was studied
- Patients with high brachial plexus injury who underwent the Oberlin Procedure to restore elbow flexion
- Wavelengths
- 808 nm
- Limits stated in the abstract
- The abstract reports a small sample of 14 patients split into two groups, and no further detail on blinding or follow-up beyond 6 months is given.
Written by an AI model from this paper’s abstract only and checked automatically against it, but it can still be wrong. It is not medical advice. Read the full paper. See the editorial policy.
Abstract
The full abstract is not shown here because it is protected by the publisher’s copyright. Read it on journals.sagepub.com.
Record from PubMed, a service of the National Library of Medicine.
Light parameters mentioned
Found in the title and abstract by pattern. They may be incomplete, so check the paper before comparing studies.
- Wavelength
- 808 nm
- Energy density (fluence)
- 4 J/cm2
- Power
- 50 mW
How to read a trial: what to check before relying on this kind of research.
Terms in this paper: Photobiomodulation, Randomized controlled trial, Control group, Wavelength, Dosimetry. Each links to its definition in the glossary.
A summary of published research, not medical advice. One study rarely settles a question. See the disclaimer and how to read research.